Preloader
A hidden biological divide may help explain Alzheimer’s and chronic pain

Emerging research suggests that biological sex and genetics may play a major role in how neurological disorders develop, progress, and respond to treatment. The findings, which will be presented at Neuroscience 2026, reveal important differences that could help researchers develop more personalized approaches to treating complex brain conditions. Neuroscience 2026 is the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

Researchers are increasingly finding that certain neurological conditions can behave differently depending on a person's biological sex and genetic makeup. Understanding these differences could lead to treatments better suited to each individual's biology. Two conditions receiving particular attention are Alzheimer's disease (AD), an incurable disorder that progressively damages memory and other brain functions, and fibromyalgia, a chronic illness marked by persistent pain and fatigue that affects 2-4% of the global population. According to the World Health Organization, Alzheimer's affects between 35 and 40 million people worldwide.

Two of the new studies highlight how menopause and inherited genetic factors may influence Alzheimer's vulnerability and treatment responses.

One investigation found that people carrying genetic risk factors for Alzheimer's responded differently to menopause hormone therapy (MHT) compared with those without the same genetic risks. The effects also varied according to the particular combination of hormones used. These findings suggest that both genetic background and hormone therapy formulation deserve consideration when evaluating treatment options. (Mateja Perović, University of Toronto)

Source: ScienceDaily - Neuroscience — Read the full article on the original site ↗